Health and FitnessHealth and Fitness
Wed, April 20, 2011
Tue, April 19, 2011
[ Tue, Apr 19th 2011 ] - Market Wire
AES to Acquire DPL

Obagi Medical Products Recognized as #1 Professional Skin Care Brand in the Medical Care Provider Channel in 2010


Published on 2011-04-19 13:10:39 - Market Wire
  Print publication without navigation


LONG BEACH, Calif.--([ BUSINESS WIRE ])--Obagi Medical Products, Inc. (Nasdaq:OMPI), a leader in topical aesthetic and therapeutic skin health systems, has once again been recognized as the #1 brand and company in the medical provider channel as reported in the Professional Skin Care 2010 report published by Kline & Co. Kline also reported that Obagi experienced the largest growth in market share (as represented in dollars) in a competitive market.

"We are proud to have again achieved recognition as the #1 brand and company"

aWe are proud to have again achieved recognition as the #1 brand and company,a Jim Hartman, Vice President of Global Marketing and Business Development at Obagi Medical, said. aIt is equally rewarding for us to see those efforts result in growing share in a competitive market, a testament to our outstanding sales team. We intend to remain focused on supporting our customers in growing their businesses and developing and launching products that meet the needs and exceed the expectations of the Obagi user.a

Obagi most recently launched Obagi Blue Peel RADIANCEa", a professional, salicylic-acid based peel, and Nu-Derm® Sun Shield SPF 50, a comprehensive, high sun protection sunscreen lotion.

About Obagi Medical Products, Inc.

Obagi Medical Products is a specialty pharmaceutical company that develops, markets and sells, and is a leading provider of, proprietary topical aesthetic and therapeutic prescription-strength skin care systems in the physician-dispensed market. Using its Penetrating Therapeuticsa" technologies, Obagi Medical's products are designed to improve penetration of agents across the skin barrier for common and visible skin conditions in adult skin including premature aging, photodamage, hyperpigmentation (irregular or patchy discoloration of the skin), acne, sun damage, rosacea, and soft tissue deficits, such as fine lines and wrinkles. The history of Obagi's skin care product introductions is as follows: Obagi Nu-Derm®, Obagi-C® Rx (a prescription-strength vitamin C and hydroquinone system), Obagi® Professional-C (a line of highly stable vitamin C serums), Obagi Condition & Enhance® for use with cosmetic procedures to enhance patient outcomes and satisfaction, Obagi ELASTIderm® Eye Treatment and Obagi CLENZIderm® M.D. acne therapeutic systems, a formulation of Obagi CLENZIderm M.D. Systems for normal to dry skin, and Obagi ELASTIderm D©colletage System, Obagi Rosaclear® System, Obagi ELASTILasha" Eyelash Solution, Obagi Blue Peel RADIANCEa", and Nu-Derm® Sun Shield SPF 50. Visit [ www.obagi.com ] for information.

Blue Peel RADIANCE, ELASTIlash and Penetrating Therapeutics are trademarks, and Obagi, Blue Peel, Condition & Enhance, ELASTIderm, Nu-Derm, Obagi-C, Obagi CLENZIderm and Rosaclear are registered trademarks, of Obagi Medical Products, Inc. and/or its affiliates in the United States and certain other countries.